Penn Medicine developed gene therapy to treat Duchenne muscular dystrophy (DMD
On Oct. 7, 2019, Penn Medicine announced it had developed gene therapy to treat Duchenne muscular dystrophy (DMD)…
On Oct. 7, 2019, Penn Medicine announced it had developed gene therapy to treat Duchenne muscular dystrophy (DMD)…
On Oct. 3, 2019, the New York State Department of Health announced that more than 42 days –…
On Oct. 2, 2019, the Masonic Cancer Center and the University of Minnesota (UM) opened a new first-in-human…
On Oct 1, 2019, the National Institute on Aging (NIA) announced it had awarded approximately $37 million over…
On Sept. 30, 2019, the University of Georgia (UGA) announced it had signed a contract with the National…
On Sept. 30, 2019, UPenn’s Center for Neurodegenerative Disease Research (CNDR) received an $18.1 million grant from the…
On Sept. 26, 2019, Seattle Children’s announced it was one of three recipients of $30 million in first-year-funding…
On Sept. 25, 2019, UPenn researchers led by Rebecca Wells, MD, announced they had created the first-ever ‘bile…
On Sept. 24, 2019, the American Academy of Family Physicians (AAFP), American Academy of Pediatrics (AAP), American College…
On Sept. 23, 2019, the Barbara Ann Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center…
On Sept. 23, 2019, Pascal Biosciences identified specific cannabinoids that enhance the immunogenicity of tumor cells, rendering them…
On Sept. 12, 2019, UPenn completed its exclusive, 7-year research and development alliance with Novartis, that spawned the…
On Sept. 11, 2019, deCODE genetics in Iceland announced an agreement with a consortium of government, charity, researchers…
On Sept. 11, 2019, scientists at Sanford Burnham Prebys announced they had identified the long-sought structure of an…
On Sept. 9, 2019, IRBM announced the signing of a service and development agreement with The University of…
On Sept. 5, 2019, researchers at the Howard Hughes Medical Instituteï¾’s Janelia Research Campus announced that they had…
On Aug. 26, 2019, University of Alberta researcher Rick Rachubinski and colleagues announced they had discovered the protein…
On Aug. 26, 2019, Amgen acquired worldwide rights to Otezlaï¾® (apremilast), the only oral, non-biologic treatment for psoriasis…
On Aug. 26, 2019 , the City of Port St. Lucie Council voted 5 to 0 to ï¾ leaseï¾ …
On Aug. 23, 2019, the Centers for Disease Control and Prevention (CDC) released Immunization Practices Advisory Committee (ACIP)…
On Aug. 21, 2019, the Siteman Cancer Center announced it was awarded a $15 million grant to better…
On Aug. 16, 2019, the Centers for Disease Control and Prevention (CDC) published updated Immunization Practices Advisory Committee…
On Aug. 15, 2019, Masonic Cancer Center researchers Reuben Harris, PhD and Douglas Yee, MD announced that they…
On Aug. 15, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it was awarded…
On Aug. 1, 2019 the Siteman Cancer Center announced it was awarded a six-year, $7.8 million grant from…
On Jul. 25, 2019, Vanderbilt University Medical Center Professor David Cortez, PhD and colleagues revealed a new DNA…
On Jul. 24, 2019, the Oregon Health Science University (OHSU) Transplant Program – one of the oldest, largest…
On Jul. 19, 2019, the Centers for Disease Control and Prevention (CDC) published recommendations from the Advisory Committee…
On Jul. 18, 2019, Chembio Diagnostics announced a collaboration with Shire Human Genetic Therapies, a wholly owned subsidiary…
On Jul. 9, 2019, the Masonic Cancer Center announced that researcher Ingunn Stromnes, PhD was awarded with a…